Literature DB >> 34810213

Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis.

Kaisa L Hanley1, Yan Liang1, Gaowei Wang2, Xiaoxue Lin1, Meixiang Yang3, Michael Karin4, Wenxian Fu3, Gen-Sheng Feng1,2.   

Abstract

The Ras/Erk and NF-κB pathways play critical roles in cell proliferation and are known to drive oncogenesis when overactivated. Herein we report a gatekeeper function of the two pathways by working in synergy to suppress liver tumorigenesis. Hepatocyte-specific deletion of both Shp2/Ptpn11 and Ikkβ in mice, which promote Ras/Erk and NF-κB signaling, respectively, exacerbated chemical carcinogenesis and even triggered spontaneous development of hepatocellular carcinoma (HCC). We show that the unanticipated severe tumor phenotype was contributed collectively by severe cholestasis, metabolic changes, upregulated cell-cycle progression, and disruption of circadian rhythm in mutant hepatocytes. Remarkably, human HCCs with dysregulated circadian gene expression displayed downregulation of Ras/Erk and NF-κB signaling and poor prognosis. Together, these data indicate that at the ground state, the two central pathways, previously known as oncogenic, cooperate to sustain tumor-suppressive physiologic homeostasis and to prevent hepatic damage. Disruption of this intricate signaling network is carcinogenic in the liver. IMPLICATIONS: We demonstrate here that basal levels of the Ras/MAPK and NF-κB pathways, while promoting tumorigenesis if overactivated, are required to maintain physiologic homeostasis and regulate circadian rhythm in the liver, which are antitumorigenic. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34810213      PMCID: PMC8898265          DOI: 10.1158/1541-7786.MCR-21-0479

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   6.333


  27 in total

Review 1.  Molecular classification of hepatocellular adenoma in clinical practice.

Authors:  Jean-Charles Nault; Valérie Paradis; Daniel Cherqui; Valérie Vilgrain; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2017-07-19       Impact factor: 25.083

2.  NIK-IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation.

Authors:  Paulina Kucharzewska; Chrissta X Maracle; Kim C M Jeucken; Jan Piet van Hamburg; Elisabeth Israelsson; Mark Furber; Sander W Tas; Henric K Olsson
Journal:  J Cell Sci       Date:  2019-04-03       Impact factor: 5.285

3.  Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells.

Authors:  Xiaolin Luo; Rui Liao; Kaisa L Hanley; Helen He Zhu; Kirsten N Malo; Carolyn Hernandez; Xufu Wei; Nissi M Varki; Nazilla Alderson; Catherine Chu; Shuangwei Li; Jia Fan; Rohit Loomba; Shuang-Jian Qiu; Gen-Sheng Feng
Journal:  Cell Rep       Date:  2016-12-13       Impact factor: 9.423

4.  Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.

Authors:  Emilie A Bard-Chapeau; Shuangwei Li; Jin Ding; Sharon S Zhang; Helen H Zhu; Frederic Princen; Diane D Fang; Tao Han; Beatrice Bailly-Maitre; Valeria Poli; Nissi M Varki; Hongyang Wang; Gen-Sheng Feng
Journal:  Cancer Cell       Date:  2011-05-17       Impact factor: 31.743

5.  PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.

Authors:  Rebecca J Chan; Gen-Sheng Feng
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

Review 6.  Advances in targeted therapies for hepatocellular carcinoma in the genomic era.

Authors:  Josep M Llovet; Augusto Villanueva; Anja Lachenmayer; Richard S Finn
Journal:  Nat Rev Clin Oncol       Date:  2015-06-09       Impact factor: 66.675

7.  IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

Authors:  Shin Maeda; Hideaki Kamata; Jun-Li Luo; Hyam Leffert; Michael Karin
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

8.  Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.

Authors:  Ying-Nan P Chen; Matthew J LaMarche; Ho Man Chan; Peter Fekkes; Jorge Garcia-Fortanet; Michael G Acker; Brandon Antonakos; Christine Hiu-Tung Chen; Zhouliang Chen; Vesselina G Cooke; Jason R Dobson; Zhan Deng; Feng Fei; Brant Firestone; Michelle Fodor; Cary Fridrich; Hui Gao; Denise Grunenfelder; Huai-Xiang Hao; Jaison Jacob; Samuel Ho; Kathy Hsiao; Zhao B Kang; Rajesh Karki; Mitsunori Kato; Jay Larrow; Laura R La Bonte; Francois Lenoir; Gang Liu; Shumei Liu; Dyuti Majumdar; Matthew J Meyer; Mark Palermo; Lawrence Perez; Minying Pu; Edmund Price; Christopher Quinn; Subarna Shakya; Michael D Shultz; Joanna Slisz; Kavitha Venkatesan; Ping Wang; Markus Warmuth; Sarah Williams; Guizhi Yang; Jing Yuan; Ji-Hu Zhang; Ping Zhu; Timothy Ramsey; Nicholas J Keen; William R Sellers; Travis Stams; Pascal D Fortin
Journal:  Nature       Date:  2016-06-29       Impact factor: 49.962

9.  Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Jordi Bruix; Shukui Qin; Philippe Merle; Alessandro Granito; Yi-Hsiang Huang; György Bodoky; Marc Pracht; Osamu Yokosuka; Olivier Rosmorduc; Valeriy Breder; René Gerolami; Gianluca Masi; Paul J Ross; Tianqiang Song; Jean-Pierre Bronowicki; Isabelle Ollivier-Hourmand; Masatoshi Kudo; Ann-Lii Cheng; Josep M Llovet; Richard S Finn; Marie-Aude LeBerre; Annette Baumhauer; Gerold Meinhardt; Guohong Han
Journal:  Lancet       Date:  2016-12-06       Impact factor: 79.321

10.  Unconjugated Bile Acids Influence Expression of Circadian Genes: A Potential Mechanism for Microbe-Host Crosstalk.

Authors:  Kalaimathi Govindarajan; John MacSharry; Patrick G Casey; Fergus Shanahan; Susan A Joyce; Cormac G M Gahan
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

View more
  1 in total

1.  Temporal analyses of postnatal liver development and maturation by single-cell transcriptomics.

Authors:  Yan Liang; Kota Kaneko; Bing Xin; Jin Lee; Xin Sun; Kun Zhang; Gen-Sheng Feng
Journal:  Dev Cell       Date:  2022-02-07       Impact factor: 12.270

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.